Total planned funding: $367,643,682
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $159,977,560 |
Zambia | $63,056,131 |
Mozambique | $33,488,531 |
Vietnam | $20,243,850 |
Kenya | $13,805,661 |
South Africa | $13,619,311 |
Tanzania | $10,752,881 |
Botswana | $6,679,720 |
Papua New Guinea | $6,494,909 |
Democratic Republic of the Congo | $5,990,245 |
Côte d'Ivoire | $5,191,571 |
Guyana | $4,375,000 |
Uganda | $3,423,638 |
Rwanda | $3,401,414 |
Ethiopia | $3,198,267 |
Ghana | $2,750,000 |
Angola | $2,250,000 |
South Sudan | $1,700,000 |
Namibia | $1,660,293 |
Eswatini | $1,620,000 |
India | $1,422,700 |
Burundi | $917,000 |
Malawi | $500,000 |
Indonesia | $405,000 |
Haiti | $270,000 |
Lesotho | $250,000 |
Dominican Republic | $200,000 |
Caribbean Region | $0 |
Organizational Types
NGO | $367,643,682 |
Program Areas
Care | $96,745,066 |
Treatment | $91,192,141 |
Prevention | $73,133,483 |
Governance and Systems | $29,924,469 |
Testing | $21,802,523 |
Budget Codes
HTXS: Treatment: Adult Treatment | $79,698,197 |
HBHC: Care: Adult Care and Support | $41,976,011 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $39,943,779 |
HKID: Care: Orphans and Vulnerable Children | $39,209,602 |
HVOP: Sexual Prevention: Other Sexual Prevention | $23,152,749 |
HVCT: Testing: HIV Testing and Counseling | $21,802,523 |
HLAB: Laboratory Infrastructure | $13,642,033 |
PDTX: Treatment: Pediatric Treatment | $11,493,944 |
OHSS: Health Systems Strengthening | $9,839,653 |
HVTB: Care: TB/HIV | $8,970,117 |
PDCS: Care: Pediatric Care and Support | $6,589,336 |
HVSI: Strategic Information | $6,442,783 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,549,103 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,536,497 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,537,533 |
HMIN: Biomedical Prevention: Injection Safety | $328,793 |
HMBL: Biomedical Prevention: Blood Safety | $85,029 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$367,643,682
View countries